Please try another search
For the nine months ended 30 September 2019,Bioelife Corp revenues was not reported. Net loss totaled$74K vs. income of $178K. Net loss reflects Gain on sale ofmineral property decrease from $675K (income) to $0K,General and administrative increase from $9K to $21K(expense), Professional fees increase of 16% to $29K(expense). Basic Earnings per Share excluding ExtraordinaryItems decreased from $0.07 to -$0.02.
Period Ending: | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 0 | 0 |
Gross Profit | ||||
Operating Income | -0.02 | -0.02 | -0.03 | 0.65 |
Net Income | -0.05 | -0.11 | 0.08 | -0.52 |
Period Ending: | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Total Assets | 0.05 | 0.11 | 0.22 | 0.14 |
Total Liabilities | 0.04 | 0.06 | 0.46 | 0.47 |
Total Equity | 0.01 | 0.06 | -0.24 | -0.33 |
Period Ending: | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | -0.1 | -0.06 | -0.03 | -0.08 |
Cash From Investing Activities | 0.11 | 0.08 | 0.05 | 0.06 |
Cash From Financing Activities | 0 | 0 | 0.02 | |
Net Change in Cash | 0.01 | 0.02 | 0.02 | 0 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review